• Chronic pain: Watch out before accepting diagnosis and treatment

    by  • 10 November 2011 • Pain News

    Experts argue that patients should be diligent in demanding proof of safety and benefit before beginning chronic pain treatment, as some medications have little evidence that they alleviate conditions for which they are prescribed. The experts dispel myths surrounding chronic Lyme disease, using it as an example of why patients ensure that diagnostic and treatment tools are approved by the FDA and not just recommended by other patients and physicians.


    After thirty years in the investment and public relations field, we have switched our focus lobbing between American and European companies facilitating business and licensing opportunities . Starting in the year 2003 L.G.Zangani, LLC has organized the annual event "Pharmafinance" in Milano and Roma. Pharmafinance is unique in its structure and has the ability to expose opportunities generated offering licensing or developing opportunities. Recently we have started the site www.letcombatpain.com creating the first worldwide site for pain news. The site also offers an humanitarian tools where individuals or professionals confronted by unique and rare forms of pain can communicate with all the members of the group simply sending oneemail. This ability of having a mass communication tool can also be used to expose innovative pain products or ideas. Additionally has also been invited as speaker to several conferences in Europe to discuss the uniqueness and functionality of his site .